Navigation Links
ViroPharma Announces Presentation of Additional HCV-796 Data at,Meeting of The European Association for the Study of the Liver

on with peg-IFN has been completed. Combination therapy including HCV-796 was found to be generally well tolerated. The observed safety profile supports the evaluation of HCV-796 in studies of longer duration.

-- Adverse events across all dose cohorts were generally mild to moderate in severity and were characteristic of the known side effects of interferons.

-- Adverse events that occurred at a frequency of greater than 15 percent across all dose cohorts of HCV-796 plus peg-IFN and peg-IFN alone included headache, chills, myalgias, fever, pain, arthralgia and rash.

-- There were two reports of serious adverse events: one in the placebo arm (pneumonia), and one in the 1000 mg combination cohort (seizure and rhabdomyolysis in a subject receiving high dose methadone chronically).

-- The rate of discontinuation due to adverse events was low across the study. No patient discontinued due to adverse events in the 100, 250, or 500 mg dose cohorts. In the peg-IFN alone group, one patient discontinued due to hypertension; of those that received 1000 mg HCV-796 plus peg-IFN, three patients discontinued due to either vasovagal syncope after a blood draw, rash, or seizure and rhabdomyolysis (in a subject receiving high dose methadone chronically).

-- No dose-limiting toxicities were identified across the range of study doses.

Genetic Sequencing

NS5B sequencing was performed on 36 subjects (11 on peg-IFN alone; 25 HCV- 796 and peg-IFN). Consistent with data from the Phase 1b study of HCV-796 as monotherapy, the only variant of importance detected in patients receiving HCV-796 was a C316Y variant known to have reduced susceptibility to HCV-796. Baseline sequencing did not find any variation from wild type at this position. The C316Y variant was observed in 7 (28 percent) of patients on HCV- 796 plus peg-IFN, occurring less frequently than previously seen in patients receiving HCV-796 as monotherapy, and was not clearly associated w
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:6/18/2013)... , June 18, 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ... focused on the development and commercialization of novel bile ... the pricing of an underwritten public offering of 1,730,000 ... price of $33.01 per share.  In addition, Intercept has ... to an additional 259,500 shares of common stock. ...
(Date:6/18/2013)... PROSPECT, Ill. , June 18, 2013 /PRNewswire-iReach/ ... of its new X3130 Appliance Inlet Module. The ... circuit breaker , combines a C14 appliance inlet ... one compact package.  This three-in-one device allows design ... their designs - cutting installation time by 66 ...
(Date:6/18/2013)... ROCKY HILL, Conn. , June 18, 2013 ... many past clients of Alliance Seating and Mobility, ... now unable to access timely repair. This appears ... and a dramatic reduction of field service employees.  ... Unfortunately a great many of these clients ...
Breaking Medicine Technology:Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2Three-in-One X3130 Appliance Inlet Module 2
... Mylan Inc. (Nasdaq: MYL ) today ... final approval from the U.S. Food and Drug Administration ... Pantoprazole Sodium Delayed-release (DR) Tablets USP, 20 mg (base) ... Protonix® DR Tablets, a treatment for the irritation of ...
... ICAP Ocean Tomo , the ... the world,s premier patent auction firm, announces the sale ... Consisting of seven issued patents and seven related applications ... to companies involved in areas such as lighting, x-ray, ...
Cached Medicine Technology:Cutting Edge Nanotech Patents for Displays, Lighting, X-ray, Medical Imaging, and Diagnostics Available for Sale by ICAP Ocean Tomo 2
(Date:6/19/2013)... FL (PRWEB) June 19, 2013 Ultimate ... Children's Telethon, an 11.5-hour broadcast on WFLA News Channel ... has collected more than $84 million for All Children's ... 2013, event, themed "30 Years of Miracles," marked the ... hour, 18 UMA employees worked the phones during the ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Next ... a premier kids entertainment media organization, and ... games company, will be introducing the Games for ... The 3D game is geared toward students in ... and active lifestyles by rewarding positive choices. The ...
(Date:6/19/2013)... Riverside, CA (PRWEB) June 19, 2013 Recently, ... Arc of Riverside County held their third in a series ... the National Wall of Respect and helped place the mosaic tiles ... Erin Maxwell and her parents, Cathy and Greg Maxwell. , ... result of an idea that took root over three years ago ...
(Date:6/19/2013)... 2013 Maui'd Forever , Hawaii's ... being an effective and cost effective way to provide ... partnered up with Tom Barefoot’s Tours providing an activity ... of Hawaii’s activities. , They have just released a ... the lowest prices on their Hawaii activities. , ...
(Date:6/19/2013)... June 19, 2013 According to Transparency ... Market Share, Trends, Analysis and Forecast, 2011 – 2017,” ... billion in the year 2011 and is expected to ... CAGR of 9.7% from 2011 to 2017. Flexible endoscopes ... contributing about USD 2,201 million for the year 2011. ...
Breaking Medicine News(10 mins):Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 2Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 3Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 2Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 3Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 4Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 5Health News:Arc Creates Huge Mosaic Mural to Highlight the Need for Greater Respect of People with Disabilities 2Health News:Maui'd Forever Pleased to Offer Price Guarantee on Hawaii Activities 2Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 2Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 3
... The Simmons firm, a leading national law firm in the ... second Miles for Meso 5K run/walk on Sunday, October 11, ... at www.milesformeso.org . , The Simmons ... 26 in Alton, Ill. Nearly 500 runners and walkers registered, ...
... ... the return of PRE-PEN® penicillin allergy skin testing products to the market. PRE-PEN® received ... with AllerQuest to market and distribute PRE-PEN®. , ... Round Rock, TX (PRWEB) September 30, 2009 -- ALK-Abelló, ...
... play a role, expert contends, , WEDNESDAY, Sept. 30 (HealthDay ... of surgery, not just the rate of those complications, determines ... , The study, which included more than 84,000 people who ... difference in surgical deaths between hospitals with the lowest rate ...
... , CARLSBAD, Calif., Sept. 30 Jenny Craig, Inc., one ... actress and comedian Nicole Sullivan as the newest Jenny Craig ... gave birth to her second child in August 2009, is ... 35 pounds. , (Photo: http://www.newscom.com/cgi-bin/prnh/20090930/NY84610 ...
... 30 Healthcare Realty Trust Incorporated (NYSE: HR ) ... credit facility, which replaces the previous $400 million facility. ... 2012. The facility is priced at 2.80% over LIBOR, ... terms and conditions customary for loans of this nature. ...
... among those with OCD or Tourette syndrome ... have suggested that strep throat may cause or trigger ... has found no evidence of a link. , ... much rarer neuropsychiatric disorders," Dr. Anette Schrag of the ...
Cached Medicine News:Health News:Simmons Law Firm Presents Second 'Miles for Meso' Walk/Run Fundraiser for Mesothelioma Research 2Health News:FDA Approves PRE-PEN Penicillin Allergy Test 2Health News:Surgical Deaths Linked to Handling of Complications 2Health News:Surgical Deaths Linked to Handling of Complications 3Health News:Nicole Sullivan Joins Jenny Craig to Reclaim Her Pre-Baby Body 2Health News:Healthcare Realty Trust Announces New $550 Million Unsecured Revolving Credit Facility 2Health News:Study Debunks Link Between Strep and Brain Disorders 2
Immersion oils may crystallize on storage. Can be redissolved on heating to 50ºC (1-2 hours)...
Immersion oil for microscopy...
... Type DF is the highest resolution ... microscopy and it also exhibits extremely ... FF has virtually zero fluorescence and ... oil of choice when low levels ...
... - the ones to compare with, the ones ... in the development and standardization of immersion oil ... , When the FDA set general purpose reagent ... in the 1970's, Cargille Immersion Oils were already ...
Medicine Products: